FDANews
FDAnews Device Daily Bulletin

Neural Analytics Secures $10M in Financing

Dec. 22, 2015

Neural Analytics, which focuses on brain health, has secured $10 million in Series A financing to support clinical trials of products in 2016.

The funding — which includes new investors JSR Limited and Taiyu Capital — also will support the ongoing development of new products and studies on traumatic brain injury, including in athletes who play sports with a high concussion risk.

According to the company, an estimated 1.7 million people every year suffer from traumatic brain injury, while another 3.8 million Americans experience a concussion. — Michael Cipriano